Romanov Andrej, Bach Michael, Yang Shan, Franzeck Fabian C, Sommer Gregor, Anastasopoulos Constantin, Bremerich Jens, Stieltjes Bram, Weikert Thomas, Sauter Alexander Walter
Department of Radiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031 Basel, Switzerland.
Department of Research & Analytic Services, University Hospital Basel, University of Basel, Spitalstrasse 8, 4031 Basel, Switzerland.
Diagnostics (Basel). 2021 Apr 21;11(5):738. doi: 10.3390/diagnostics11050738.
CT patterns of viral pneumonia are usually only qualitatively described in radiology reports. Artificial intelligence enables automated and reliable segmentation of lungs with chest CT. Based on this, the purpose of this study was to derive meaningful imaging biomarkers reflecting CT patterns of viral pneumonia and assess their potential to discriminate between healthy lungs and lungs with viral pneumonia. This study used non-enhanced and CT pulmonary angiograms (CTPAs) of healthy lungs and viral pneumonia (SARS-CoV-2, influenza A/B) identified by radiology reports and RT-PCR results. After deep learning segmentation of the lungs, histogram-based and threshold-based analyses of lung attenuation were performed and compared. The derived imaging biomarkers were correlated with parameters of clinical and biochemical severity (modified WHO severity scale; c-reactive protein). For non-enhanced CTs ( = 526), all imaging biomarkers significantly differed between healthy lungs and lungs with viral pneumonia (all < 0.001), a finding that was not reproduced for CTPAs ( = 504). Standard deviation (histogram-derived) and relative high attenuation area [600-0 HU] (HU-thresholding) differed most. The strongest correlation with disease severity was found for absolute high attenuation area [600-0 HU] (r = 0.56, 95% CI = 0.46-0.64). Deep-learning segmentation-based histogram and HU threshold analysis could be deployed in chest CT evaluation for the differentiating of healthy lungs from AP lungs.
病毒性肺炎的CT表现通常仅在放射学报告中进行定性描述。人工智能可实现胸部CT对肺的自动且可靠的分割。基于此,本研究的目的是得出反映病毒性肺炎CT表现的有意义的影像生物标志物,并评估其区分健康肺与病毒性肺炎肺的潜力。本研究使用了由放射学报告和逆转录-聚合酶链反应(RT-PCR)结果确定的健康肺和病毒性肺炎(严重急性呼吸综合征冠状病毒2、甲型/乙型流感)的非增强CT及CT肺血管造影(CTPA)。在对肺进行深度学习分割后,对肺衰减进行了基于直方图和基于阈值的分析并进行比较。得出的影像生物标志物与临床和生化严重程度参数(改良的世界卫生组织严重程度量表;C反应蛋白)相关。对于非增强CT(n = 526),健康肺与病毒性肺炎肺之间所有影像生物标志物均有显著差异(均P < 0.001),而CTPA(n = 504)未再现这一发现。标准差(源自直方图)和相对高衰减面积[600 - 0 HU](HU阈值法)差异最大。绝对高衰减面积[600 - 0 HU]与疾病严重程度的相关性最强(r = 0.56,95%置信区间 = 0.46 - 0.64)。基于深度学习分割的直方图和HU阈值分析可用于胸部CT评估,以区分健康肺与病毒性肺炎肺。